Role of osteopontin in the development of neointimal hyperplasia in vein grafts

European Journal of Cardio-thoracic Surgery

Volumn 41, Issue 6, 2012, Pages 1384-1389

  Kang, Ning ^a   Ng, Calvin S H ^a   Qiu, Zhi Bing ^a   Underwood, Malcolm J ^a   Jeremy, Jamie Y ^b   Wan, Song ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Coronary artery bypass grafting; Medial thickness; Neointima; Osteopontin; Vein graft

Indexed keywords

CYCLINE; MATRIX METALLOPROTEINASE; OSTEOPONTIN; GELATINASE A; GELATINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL PIG; HISTOPATHOLOGY; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; NEOINTIMAL HYPERPLASIA; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; VEIN GRAFT DISEASE; WESTERN BLOTTING; ANASTOMOSIS; ANIMAL; CAROTID ARTERY; CELL PROLIFERATION; CORONARY ARTERY BYPASS GRAFT; GRAFT REJECTION; HYPERPLASIA; INTIMA; METABOLISM; METHODOLOGY; NEOINTIMA; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SAPHENOUS VEIN; SWINE; TRANSPLANTATION; VASCULAR SMOOTH MUSCLE;

ANASTOMOSIS, SURGICAL; ANIMALS; CAROTID ARTERIES; CELL PROLIFERATION; CORONARY ARTERY BYPASS; GRAFT REJECTION; HYPERPLASIA; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MUSCLE, SMOOTH, VASCULAR; NEOINTIMA; OSTEOPONTIN; PROLIFERATING CELL NUCLEAR ANTIGEN; SAPHENOUS VEIN; SUS SCROFA; TUNICA INTIMA;

EID: 84865370152     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezr200     Document Type: Article

References (25)

1. Kolh P, Wijns W, Danchin N, Di Mario C, Falk V, Folliguet T et al. Guidelines on myocardial revascularization. Task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg 2010;38(Suppl.):S1-S52.
2. Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 1998;97: 916-31.
3. Muto A, Model L, Ziegler K, Eghbalieh SD, Dardik A. Mechanisms of vein graft adaptation to the arterial circulation: insights into the intimal algorithm and management strategies. Circ J 2010;74:1501-12.
4. Senger DR, Wirth DF, Hynes RO. Transformed mammalian cells secrete specific proteins and phosphoproteins. Cell 1979;16:885-93.
5. Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 2001;107:1055-61.
6. Scatena M, Liaw L, Giachelli CM. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 2007;27:2302-9.
7. Ohmori R, Momiyama Y, Taniguchi H, Takahashi R, Kusuhara M, Nakamura H et al. Plasma osteopontin levels are associated with the presence and extent of coronary artery disease. Atherosclerosis 2003; 170:333-7.
8. Isoda K, Nishikawa K, Kamezawa Y, Yoshida M, Kusuhara M, Moroi M et al. Osteopontin plays an important role in the development of medial thickening and neointimal formation. Circ Res 2002;91:77-82.
9. Leali D, Moroni E, Bussolino F, Presta M. Osteopontin overexpression inhibits in vitro re-endothelialization via integrin engagement. J Biol Chem 2007;282:19676-84.
10. Liaw L, Almeida M, Hart CE, Schwartz SM, Giachelli CM. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ Res 1994;74:214-24.
11. Sun J, Xu Y, Dai Z, Sun Y. Intermittent high glucose enhances proliferation of vascular smooth muscle cells by upregulating osteopontin. Mol Cell Endocrinol 2009;313:64-9.
12. Matsui Y, Rittling SR, Okamoto H, Inobe M, Jia N, Shimizu T et al. Osteopontin deficiency attenuates atherosclerosis in female apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2003;23:1029-34.
13. Wan S, George SJ, Nicklin SA, Yim APC, Baker AH. Overexpression of p53 increases lumen size and blocks neointima formation in porcine interposition vein grafts. Mol Ther 2004;9:689-98.
14. Wan S, Yim APC, Johnson JL, Shukla N, Angelini GD, Smith FCT et al. The endothelin-1A receptor antagonist BSF 302146 is a potent inhibitor of neointimal and medial thickening in porcine saphenous vein-carotid artery interposition grafts. J Thorac Cardiovasc Surg 2004;127:1317-22.
15. Wan S, Arifi AA, Chan MCW, Yip JHY, Ng CSH, Chow LTC et al. Differential, time-dependent effects of perivenous application of fibrin glue on medial thickening in porcine saphenous vein grafts. Eur J Cardiothorac Surg 2006;29:742-7.
16. Wan S, Shukla N, Angelini GD, Yim APC, Johnson JL, Jeremy JY. Nitric oxide-donating aspirin (NCX 4016) inhibits neointimal thickening in a pig model of saphenous vein-carotid artery interposition grafting: a comparison with aspirin and morpholinosydnonimine (SIN-1). J Thorac Cardiovasc Surg 2007;134:1033-9.
17. O'Brien ER, Garvin MR, Stewart DK, Hinohara T, Simpson JB, Schwartz SM et al. Osteopontin is synthesized by macrophages, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscler Thromb 1994;14:1648-56.
18. Giachelli CM, Bae N, Almeida M, Denhardt DT, Alpers CE, Schwartz SM. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest 1993; 92:1686-96.
19. Jalvy S, Renault MA, Leen LL, Belloc I, Bonnet J, Gadeau AP et al. Autocrine expression of osteopontin contributes to PDGF-mediated arterial smooth muscle cell migration. Cardiovasc Res 2007;75:738-47.
20. George SJ, Wan S, Hu J, Johnson JL, MacDonald R, Baker AH. Sustained reduction of vein graft neointima formation by ex vivo TIMP-3 gene therapy. Circulation 2011;124(11 Suppl):S135-42.
21. Chase AJ, Newby AC. Regulation of matrix metalloproteinase (matrixin) genes in blood vessels: a multi-step recruitment model for pathological remodelling. J Vasc Res 2003;40:329.
22. Berceli SA, Jiang Z, Klingman NV, Schultz GS, Ozaki CK. Early differential MMP-2 and -9 dynamics during flow-induced arterial and vein graft adaptations. J Surg Res 2006;134:327-34.
23. Seipelt RG, Backer CL, Mavroudis C, Stellmach V, Cornwell M, Seipelt IM et al. Local delivery of osteopontin attenuates vascular remodeling by altering matrix metalloproteinase-2 in a rabbit model of aortic injury. J Thorac Cardiovasc Surg 2005;130:355-62.
24. Johansson BL, Souza DS, Bodin L, Filbey D, Loesch A, Geijer H et al. Slower progression of atherosclerosis in vein grafts harvested with 'no touch' technique compared with conventional harvesting technique in coronary artery bypass grafting: an angiographic and intravascular ultrasound study. Eur J Cardiothorac Surg 2010;38:414-9.
25. Semsroth S, Stigler RG, Bernecker OY, Ruttmann-Ulmer E, Troppmair J, Macfelda K et al. Everolimus attenuates neointimal hyperplasia in cultured human saphenous vein grafts. Eur J Cardiothorac Surg 2009;35: 515-20.